60 likes | 155 Views
Cancer therapeutics and biotherapeutic market is majorly segmented into Chemotherapy, Radiation Therapy, Hormone Therapy, Biotherapy<br>https://www.alliedmarketresearch.com/cancer-therapeutics-biotherapeutic-market<br>
E N D
www.alliedmarketresearch.com v Cancer Therapeutics and Biotherapeutic Market Size, Share, Global Trends, Company Profile, Demand, Insights, Analysis, Research, Report, Opportunities, Forecast, 2014 - 2022 Upcoming: 2017 Category: Healthcare
Cancer Therapeutics and Biotherapeutic Market Overview • Cancer is one of the leading causes of death worldwide. According to the World Health Organization, about 8.2 million deaths occurred in 2012 due to cancer. • The most common kinds of cancer which tend to result in death are lung cancer, liver cancer, stomach cancer, colorectal cancer, breast cancer and oesophageal cancer. • Apart from the mature chemotherapy market, biotherapy has emerged as a new approach for cancer treatment. • Biotherapy boosts the body’s immune system to slow or stop the growth of cancer cells. • Growing demand for personalized medicine and the introduction of novel approaches are expected to drive the market growth. • Astra Zeneca PLC, Biogen IDEC, Bristol-Myers Squibb, Sanofi, Merck, Johnson & Johnson, Schering-Plough and Roche are some players in this market.
Cancer Therapeutics and Biotherapeutic Market Overview • The cancer therapeutics and biotherapeutic market is segmented into technology and geography. • On the basis of technology, the market is segmented into Chemotherapy, radiation therapy, hormonal therapy and biotherapy. • Chemotherapy includes alkylating agents, cytotoxic agents, antimetabolites, plant derivatives and others. • Radiation therapy comprises of Intraoperative radiotherapy, external beam radiation therapy, brachytherapy and radioisotope therapy. Hormonal therapy consists of hormone antagonists, corticosteroids, aromatase inhibitors, and selective estrogen receptor modulators (SERMs.) • Biotherapy includes monoclonal antibodies, interleukins, kinases and others. Geographically, the market is segmented into North America, Europe, Asia-Pacific and LAMEA.
Key Benefits of Cancer Therapeutics and Biotherapeutic Market • The report provides in-depth analysis of the Cancer therapeutics and Biotherapeutic market, which is segmented into technology and geography to provide a better understanding of the market. • Quantitative analysis of the current market scenario as well as future estimations through 2013-2020 would help stakeholders understand the future prospects of the market. • The report analyses the factors that are driving and limiting the growth of market. • Analysis of trends in various regions would help the companies to plan their strategies depending on the region. • Analysis of key strategies adopted by market players would assist in providing in-depth understanding of market intelligence.
Cancer Therapeutics and Biotherapeutic Market Segments Cancer Therapeutics and Biotherapeutic Market by Technology • Chemotherapy • Alkylating Agents • Cytotoxic agents • Radiation Therapy • Intraoperative radiotherapy, • External beam radiation therapy • Hormone Therapy • Hormone antagonists • Corticosteroids • Biotherapy • Monoclonal antibodies • Interleukin • Kinases
Thank You! For More Details https://www.alliedmarketresearch.com/cancer-therapeutics-biotherapeutic-market Stay With US Global Head Quarters 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States. E-mail : help@alliedmarketresearch.com Telephone Direct : Toll Free : Fax : +1 (617) 674-4143 +1 (855) 711-1555 +1 (855) 550-5975